AU6256796A - Method for treating molluscum contagiosum resulting from hiv infection - Google Patents

Method for treating molluscum contagiosum resulting from hiv infection

Info

Publication number
AU6256796A
AU6256796A AU62567/96A AU6256796A AU6256796A AU 6256796 A AU6256796 A AU 6256796A AU 62567/96 A AU62567/96 A AU 62567/96A AU 6256796 A AU6256796 A AU 6256796A AU 6256796 A AU6256796 A AU 6256796A
Authority
AU
Australia
Prior art keywords
resulting
hiv infection
molluscum contagiosum
treating molluscum
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62567/96A
Inventor
D. Allen Allen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU6256796A publication Critical patent/AU6256796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU62567/96A 1995-06-06 1996-06-06 Method for treating molluscum contagiosum resulting from hiv infection Abandoned AU6256796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46735695A 1995-06-06 1995-06-06
US467356 1995-06-06
PCT/US1996/009192 WO1996039187A1 (en) 1995-06-06 1996-06-06 Method for treating molluscum contagiosum resulting from hiv infection

Publications (1)

Publication Number Publication Date
AU6256796A true AU6256796A (en) 1996-12-24

Family

ID=23855366

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62567/96A Abandoned AU6256796A (en) 1995-06-06 1996-06-06 Method for treating molluscum contagiosum resulting from hiv infection

Country Status (3)

Country Link
EP (1) EP0831907A4 (en)
AU (1) AU6256796A (en)
WO (1) WO1996039187A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002869A (en) * 1987-11-02 1991-03-26 Dana-Farber Cancer Institute Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes
AU5553290A (en) * 1989-04-28 1990-11-29 Baylor College Of Medicine Dissemination of hiv-1 infected cells
AU5568290A (en) * 1989-04-28 1990-11-29 Baylor College Of Medicine Method of suppressing hiv infection
MX9305070A (en) * 1992-08-21 1994-04-29 Genentech Inc PHARMACEUTICAL COMPOSITION CONTAINING AN LFA-1 ANTAGONIST FOR THE TREATMENT OF DISORDERS OR DISORDERS MEDIATED BY LFA-1
DK1438970T3 (en) * 1993-03-19 2008-12-15 D Allen Allen Method of Inhibiting HIV-Associated Diseases by Monoclonal Antibodies to Self-Targeted Cytotoxic Cells
WO1995028176A1 (en) * 1994-04-15 1995-10-26 Allen Allen D Method of treating hiv infection using antibodies against cytotoxic t-cells and thymic humoral factor

Also Published As

Publication number Publication date
WO1996039187A1 (en) 1996-12-12
EP0831907A1 (en) 1998-04-01
EP0831907A4 (en) 2005-05-04

Similar Documents

Publication Publication Date Title
AU6479596A (en) Methods for treating diabetes
AU4972596A (en) Improved tibial osteotomy system
AU5833196A (en) Surgical cast saw
AU2948895A (en) Landfill gas treatment system
AU4958096A (en) Process for the treatment of gases
AU7554796A (en) Trans microstructure directing initiator system
AU1466397A (en) Surgical smoke evacuation apparatus
AU5576096A (en) Method for accelerating production
AU5869990A (en) Means for surgical treatment
AU5486596A (en) Surgical method
AU693963B2 (en) Knitting method
IL116925A0 (en) Compounds for treating hiv infection
EP0767132A3 (en) Correction run for an elevator system
AU4602897A (en) Method for treatment of immunodeficiency virus infection
AU6359598A (en) Method for treating protozoal infections
AUPN359095A0 (en) Saw system
AU6256796A (en) Method for treating molluscum contagiosum resulting from hiv infection
AU6620996A (en) Gas treatment apparatus
AU7712296A (en) Device for removing bones, especially fishbones
AU7016296A (en) Sewage treatment system
AU1335397A (en) Method for treating dermatitis
AU4222996A (en) Process for growing virus
AU5011296A (en) Fibre treatment
AUPM626594A0 (en) Method of treatment of molluscum contagiosum
AU5891996A (en) Device for treating a bone recess